Quick assessment with controlled attenuation parameter for hepatic steatosis in children based on MRI-PDFF as the gold standard

[1] Schwimmer JB(2006)Prevalence of fatty liver in children and adolescents Pediatrics 118 1388-1393

[2] Deutsch R(2016)Clinical advances in pediatric nonalcoholic fatty liver disease Hepatology 63 1718-1725

[3] Kahen T(2016)Epidemiology of childhood obesity in Korea Endocrinol Metab 31 510-518

[4] Lavine JE(2018)Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis Hepatology 67 1348-1359

[5] Stanley C(2012)Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD Aliment Pharmacol Ther 36 22-29

[6] Behling C(2015)Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease Hepatology 61 1887-1895

[7] Schwimmer JB(2016)MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: clinical trials to clinical practice J Hepatol 65 1006-1016

[8] Ha KH(2018)Diagnostic accuracy of magnetic resonance imaging hepatic proton density fat fraction in pediatric nonalcoholic fatty liver disease Hepatology 67 858-872

[9] Kim DJ(2015)Elastography assessment of liver fibrosis: Society of Radiologists in ultrasound consensus conference statement Radiology 276 845-861

[10] Caussy C(2010)Controlled attenuation parameter (CAP): a novel VCTE guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes Ultrasound Med Biol 36 1825-1835

[1] Schwimmer JB(2006)Prevalence of fatty liver in children and adolescents Pediatrics 118 1388-1393

[2] Deutsch R(2016)Clinical advances in pediatric nonalcoholic fatty liver disease Hepatology 63 1718-1725

[3] Kahen T(2016)Epidemiology of childhood obesity in Korea Endocrinol Metab 31 510-518

[4] Lavine JE(2018)Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis Hepatology 67 1348-1359

[5] Stanley C(2012)Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD Aliment Pharmacol Ther 36 22-29

[6] Behling C(2015)Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease Hepatology 61 1887-1895

[7] Schwimmer JB(2016)MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: clinical trials to clinical practice J Hepatol 65 1006-1016

[8] Ha KH(2018)Diagnostic accuracy of magnetic resonance imaging hepatic proton density fat fraction in pediatric nonalcoholic fatty liver disease Hepatology 67 858-872

[9] Kim DJ(2015)Elastography assessment of liver fibrosis: Society of Radiologists in ultrasound consensus conference statement Radiology 276 845-861

[10] Caussy C(2010)Controlled attenuation parameter (CAP): a novel VCTE guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes Ultrasound Med Biol 36 1825-1835